Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2012
12/27/2012WO2012175813A1 Multivalent [beta] - 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
12/27/2012WO2012175740A1 Immunoglobulin single variable domains directed against ige
12/27/2012WO2012125413A3 Compositions for ameliorating systemic inflammation and methods for making and using them
12/27/2012WO2012012531A9 Compositions and methods featuring il-6 and il-21 antagonists
12/27/2012US20120331578 Method for Producing Recombinant Glycoproteins Having Beta1,2-Bound Xylose Residues
12/27/2012US20120330019 Hepatitis C Virus Inhibitors
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329863 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
12/27/2012US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
12/27/2012US20120329848 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
12/27/2012US20120329840 Novel modulators of sphingosine phosphate receptors
12/27/2012US20120329839 Novel modulators of sphingosine phosphate receptors
12/27/2012US20120329838 Novel modulators of sphingosine phosphate receptors
12/27/2012US20120329803 Dihydropteridinones, method for production and use thereof
12/27/2012US20120329801 Crystalline forms for 5-amino-2, 3-dihydrophthalazine-1, 4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms
12/27/2012US20120329785 Novel kinase inhibitors
12/27/2012US20120329782 Azepine inhibitors of janus kinases
12/27/2012US20120329780 Novel kinase inhibitors
12/27/2012US20120329776 Heterocyclic compounds and uses thereof
12/27/2012US20120329775 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
12/27/2012US20120329774 Thieno-pyridine derivatives as mek inhibitors
12/27/2012US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments
12/27/2012US20120329752 Allergy inhibitor
12/27/2012US20120329743 Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators
12/27/2012US20120329734 Mixture and infusion or drink solution
12/27/2012US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
12/27/2012US20120328721 Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects
12/27/2012US20120328720 Iridoid Based Formulations
12/27/2012US20120328718 Pharmaceutical compositions
12/27/2012US20120328702 Nanoparticle compositions
12/27/2012US20120328693 Method for enhancing immune response in the treatment of infectious and malignant diseases
12/27/2012US20120328667 In situ constituting a vaccine for administration to a predetermined herd of animals
12/27/2012US20120328664 Liquid formulations
12/27/2012US20120328663 Composition of Beta-Glucan and Ashwagandha
12/27/2012US20120328662 Composition for inhibiting tumor cell proliferation
12/27/2012US20120328661 Coumarin compounds as receptor modulators with therapeutic utility
12/27/2012US20120328660 Immunogenic compositions useful in provoking an integrated response to tumor antigens
12/27/2012US20120328659 Treatment of streptococcal infections
12/27/2012US20120328656 Compositions and methods for vaccinating against hsv-2
12/27/2012US20120328655 Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
12/27/2012US20120328654 Multi-phase emulsions based on amphiphilic block copolymers
12/27/2012US20120328653 Modified immunization vectors
12/27/2012US20120328652 Recombinant attenuated parvovirus
12/27/2012US20120328651 Chimpanzee adenovirus vaccine carriers
12/27/2012US20120328650 Modified vaccinia ankara virus variant
12/27/2012US20120328649 Recombinant Viral Vectors and Methods for Inducing an Immune Response to Yellow Fever Virus
12/27/2012US20120328643 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328634 Immunoconjugates with an Intracellularly-Cleavable Linkage
12/27/2012US20120328632 Inhibition of leukocyte adhesion
12/27/2012US20120328627 Chemokine receptor antagonists and use thereof
12/27/2012US20120328622 Novel compounds
12/27/2012US20120328621 Immunogens, compositons and uses thereof, method for preparing same
12/27/2012US20120328617 Method for inhibiting angiogenesis
12/27/2012US20120328615 Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
12/27/2012US20120328604 Methods and compositions for treating and preventing disease associated with avb5 integrin
12/27/2012US20120328603 Assays and methods using biomarkers
12/27/2012US20120328582 Primate Embryonic Stem Cells
12/27/2012US20120328574 P38 inhibitors
12/27/2012US20120328563 Cd4+cd25+ regulatory t cells from human blood
12/27/2012US20120328541 Anti-radical agents
12/27/2012US20120328540 Cysteinyl compounds, compositions and methods of use
12/27/2012US20120328525 Nanoparticle compositions and components thereof
12/27/2012US20120328519 Dentric polyglycerol sulfates and sulfonates and their use for inflammatory diseases
12/27/2012CA2842136A1 Multivalent [beta] - 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
12/27/2012CA2840875A1 Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
12/27/2012CA2840161A1 Method for amplifying nk cells
12/27/2012CA2839811A1 Materials and methods for modulating immune responses
12/27/2012CA2839767A1 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
12/27/2012CA2839558A1 Leukotoxin e/d as a new anti-inflammatory agent and microbicide
12/27/2012CA2839554A1 Methods of treating and preventing staphylococcus aureus infections and associated conditions
12/27/2012CA2839507A1 Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
12/27/2012CA2834618A1 Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
12/26/2012EP2537849A2 Azaindoles useful as inhibitors of janus kinases
12/26/2012EP2537831A1 Imidazole derivative
12/26/2012EP2537830A1 Compounds and compositions as protein kinase inhibitors
12/26/2012EP2537524A2 Treatment of T-cell mediated diseases
12/26/2012EP2537523A1 Prophylactic/ameliorating agent for diseases, endurance improving agent and anti-fatigue agent, and pharmaceutical agent, food and beverage each comprising any one of those agents
12/26/2012EP2536732A2 Cyclic tetrapeptides and therapeutic applications thereof
12/26/2012EP2536729A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
12/26/2012EP2536722A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors
12/26/2012EP2536432A1 Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
12/26/2012EP2536430A1 Compositions and methods for targeting type 1 interferon producing cells
12/26/2012EP2536419A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
12/26/2012CN102844317A Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
12/26/2012CN102844047A Immunogenic compositions including tlr activity modulators
12/26/2012CN102844038A Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
12/26/2012CN102844037A Probiotic containing modules for tube feeding
12/26/2012CN102844027A Novel therapeutic methods for treating inflammation and immune system disorders
12/26/2012CN102838688A Preparation method of soluble yeast glucan
12/26/2012CN102838675A Ip-10 antibodies and their uses
12/26/2012CN102838660A Small molecule polypeptides with function of inflammation immune reaction inhibition, and applications thereof
12/26/2012CN102838625A Tetrahydropyridothiazole compounds, preparation method, drug compositions containing the same, and uses thereof
12/26/2012CN102838599A Polymorphs
12/26/2012CN102838596A Pyrrolo[2,3-b]pyridine derivative, preparation method and application thereof
12/26/2012CN102836441A Method for enhancing immune response in treatment of infectious and malignant disease
12/26/2012CN102836433A Sensitizing agent used for reversing or reducing esophageal cancer radiotherapy resistance, screening method thereof, and purpose thereof
12/26/2012CN102836426A Novel immunogenic composition for prevention and treatment of meningococcal disease
12/26/2012CN102836422A Disease prevention and growth promotion magic drug
12/26/2012CN102836415A Composition for enhancing immune activity, medical composition for preventing and improving cancer
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 1172